Reduction in Extraocular Muscle Cross-sectional Area and Correlation With Extraocular Motility and Diplopia Following Teprotumumab for Thyroid Eye Disease.

Edith R Reshef, Marcela Marsiglia,Karim Bouhadjer,Carolina A Chiou,Devin O'Brien-Coon,Katherine L Reinshagen,Suzanne K Freitag

Ophthalmic plastic and reconstructive surgery（2023）

引用 0|浏览3

暂无评分

摘要

EOM CSA is significantly reduced following treatment with teprotumumab, and correlates with clinical findings including improvement in extraocular motility and diplopia.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要